首页> 外文期刊>海南医科大学学报(英文版) >Effect of ropivacaine combined with sufentanil epidural labor analgesia on pain neurotransmitters as well as cytokine production and stress hormone secretion
【24h】

Effect of ropivacaine combined with sufentanil epidural labor analgesia on pain neurotransmitters as well as cytokine production and stress hormone secretion

机译:罗哌卡因联合舒芬太尼硬膜外分娩镇痛对疼痛神经递质,细胞因子产生和应激激素分泌的影响

获取原文
获取原文并翻译 | 示例
       

摘要

Objective: To discuss the effect of ropivacaine combined with sufentanil epidural labor analgesia on pain neurotransmitters as well as cytokine production and stress hormone secretion. Methods: A total of 218 cases of puerperae who received caesarean section in the hospital between January 2015 and January 2017 were divided into control group (n=109) and observation group (n=109) by random table method. Control group received postpartum ropivacaine epidural analgesia alone, and observation group received postpartum ropivacaine combined with sufentanil epidural analgesia. The differences in serum levels of pain neurotransmitters, inflammatory factors and stress hormones were compared between the two groups immediately after childbirth (T0), 6 h after delivery (T1), 12 h after delivery (T2) and 24 h after delivery (T3). Results: At T0, the differences in serum levels of pain neurotransmitters, inflammatory factors and stress hormones were not statistically significant between the two groups. At T1, T2 and T3, serum NPY, β-EP and SP levels of observation group were lower than those of control group at corresponding points in time; serum IL-1β, hs-CRP and IL-6 levels of observation group were lower than those of control group at corresponding points in time; serum Cor, AngⅠ, AngⅡ and NE levels of observation group were lower than those of control group at corresponding points in time. Conclusion:Ropivacaine combined with sufentanil epidural analgesia after caesarean section can effectively inhibit the pain neurotransmitter expression and relieve the systemic inflammatory stress response in puerperae.
机译:目的:探讨罗哌卡因联合舒芬太尼硬膜外分娩镇痛对疼痛神经递质,细胞因子产生和应激激素分泌的影响。方法:采用随机表法将2015年1月至2017年1月在医院接受剖宫产术的产妇218例,分为对照组(n = 109)和观察组(n = 109)。对照组仅接受产后罗哌卡因硬膜外镇痛,观察组接受罗哌卡因联合舒芬太尼硬膜外镇痛。比较两组在分娩后立即(T0),分娩后6小时(T1),分娩后12小时(T2)和分娩后24小时(T3)的疼痛神经递质,炎性因子和应激激素的血清水平的差异。 。结果:在T0时,两组之间的疼痛神经递质,炎性因子和应激激素的血清水平差异无统计学意义。在T1,T2和T3时,观察组的血清NPY,β-EP和SP水平在相应的时间点均低于对照组。观察组血清IL-1β,hs-CRP和IL-6水平在相应的时间点均低于对照组。观察组血清Cor,AngⅠ,AngⅡ和NE水平在相应的时间点均低于对照组。结论:剖宫产术后应用罗哌卡因联合舒芬太尼硬膜外镇痛可有效抑制疼痛神经递质的表达,减轻产妇的全身炎症应激反应。

著录项

  • 来源
    《海南医科大学学报(英文版)》 |2017年第21期|55-59|共5页
  • 作者

    Jing-Shan Zhang;

  • 作者单位

    Anesthesiology Department, Sinopharm Dongfeng Huaguo Hospital in Shiyan Hubei Province, Shiyan City, Hubei Province, 442003;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号